Jazz Pharmaceuticals
JAZZ
#1899
Rank
A$15.52 B
Marketcap
A$255.48
Share price
1.67%
Change (1 day)
33.82%
Change (1 year)

Jazz Pharmaceuticals (JAZZ) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : A$11.13 Billion

According to Jazz Pharmaceuticals's latest financial reports the company's total liabilities are A$11.13 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Jazz Pharmaceuticals - Total liabilities on balance sheet (from 2005 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31A$12.73 B13.28%
2023-12-31A$11.23 B-1.32%
2022-12-31A$11.38 B-0.93%
2021-12-31A$11.49 B207.31%
2020-12-31A$3.74 B7.86%
2019-12-31A$3.46 B-0.13%
2018-12-31A$3.47 B12.45%
2017-12-31A$3.08 B-23.85%
2016-12-31A$4.05 B70.36%
2015-12-31A$2.38 B-1.01%
2014-12-31A$2.40 B127.51%
2013-12-31A$1.05 B29.94%
2012-12-31A$0.81 B1271.94%
2011-12-31A$59.28 M-42.75%
2010-12-31A$0.10 B-48.39%
2009-12-31A$0.20 B-32.72%
2008-12-31A$0.29 B70.88%
2007-12-31A$0.17 B-64.81%
2006-12-31A$0.49 B28.19%
2005-12-31A$0.38 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Endo International
ENDPQ
A$17.66 B 58.63%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
AmerisourceBergen
ABC
A$90.71 B 714.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$94.14 B 745.39%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Teva Pharmaceutical Industries
TEVA
A$49.08 B 340.72%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel